Kinetics meet the testing window
How Long Ipamorelin Stays in Your System: Half-Life
The ~2-hour half-life is the easy number. Detectability is the one that actually matters for sport — and they're not the same question.
Start here
People ask how long does ipamorelin stay in your system for two different reasons, and they have two different answers. If you mean how fast does the body clear it — the half-life — the answer is about 2 hours in humans [2]. After a handful of half-lives the parent peptide is essentially gone from blood. But if you mean how long can a drug test catch it — detection — that's a separate, longer, and more important question, because labs look for metabolites (breakdown products) in urine, not just the intact peptide [7]. A short half-life does not mean "undetectable." This page covers both: the clean pharmacokinetic number, then the messier detection reality that the anti-doping science actually addresses.
The pharmacokinetic answer: about 2 hours
From the human PK/PD study (eight men per dose, IV infusions of 4.21-140.45 nmol/kg over 15 minutes): terminal half-life ~2 hours, clearance 0.078 L/h/kg, steady-state volume of distribution 0.22 L/kg [2]. Kinetics were dose-proportional and linear across that range. The GH response it triggers is a single discrete pulse peaking around 40 minutes (0.67 h) post-dose [2], not a plateau. So in the bloodstream, ipamorelin is a fast in-and-out compound: a short pulse of effect, then rapid clearance. In rats, plasma clearance is roughly 5-fold lower than GHRP-6 — a species difference worth noting but not a human number.
The detection answer is the one that bites
Here's where the marketing's "it clears fast, so you're fine" logic falls apart. Anti-doping detection does not depend on the parent peptide still circulating — it depends on identifiable metabolites in urine. Analytical chemists determined growth-hormone-releasing-peptide metabolites in human urine after administration, and those methods are the basis for screening the GHRP class in accredited labs [7]. Structure-activity and excretion work confirmed receptor-active metabolites turning up in urine post-dose [8]. In other words, the body breaks ipamorelin down into pieces that the lab is specifically looking for, and the window for finding those pieces is governed by metabolite excretion, not by the 2-hour plasma half-life. Designer analogues complicate it further — Gly-Ipamorelin was caught in black-market products precisely because labs extended their methods to spot variants [9].
What this means for the WADA-prohibited status
Ipamorelin sits on the WADA Prohibited List under category S2 (peptide hormones, growth factors, related substances and mimetics), banned at all times. The whole point of the urinary-detection research [7][8] is enforceability: a banned substance that couldn't be found would be a paper tiger, and the published methods make clear ipamorelin's class is not. Two 2026 reviews reinforce that the WADA detection framework around these GH-axis peptides is expanding, not contracting [11][13]. The takeaway for the "how long does it stay in your system" question: plasma clearance is fast, but for anyone subject to testing, detectability — not half-life — is the number that governs risk, and that number is set by metabolite excretion the published science is built to catch.
The honest limits of the timeline
What the literature gives cleanly: the ~2-hour human plasma half-life [2] and the existence of validated urinary detection for the GHRP class [7][8]. What it does not give as a tidy published figure is a precise "detectable for N days after a subcutaneous dose" window for ipamorelin specifically — detection windows depend on dose, route, individual metabolism, and the exact assay, and the dominant real-world route (subcutaneous self-injection) has no published human PK at all. So the responsible summary is: half-life ~2 hours; detection, real and method-backed but not reducible to a single guaranteed number. Anyone treating a short half-life as proof of being undetectable is reading the wrong column.